Literature DB >> 3543808

Multiple cross-reactivities amongst antigens of Plasmodium falciparum impair the development of protective immunity against malaria.

R F Anders.   

Abstract

The majority of protein antigens of the malaria parasite Plasmodium falciparum contain short sequences that are extensively repeated in tandem arrays. Some antigens contain a single block of repeats whereas in other antigens there may be two or more blocks of related repeats. The repetitive sequences in an individual antigen may be highly conserved but more usually there is some degeneracy which occasionally is extensive. The repetitive sequences encode immunodominant epitopes to which much of the antibody response in malaria is directed. Recently, we have found that there are extensive cross-reactions amongst the epitopes encoded by related repetitive sequences. These cross-reactions may involve different blocks of repeats in the one antigen or repetitive sequences in different antigens. It is proposed that these cross-reactions interfere with the normal maturation of a high affinity antibody response in malaria by causing an abnormally high proportion of somatically-mutated B cells to be preserved during clonal expansion.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3543808     DOI: 10.1111/j.1365-3024.1986.tb00867.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  70 in total

1.  Levels of antibody to conserved parts of Plasmodium falciparum merozoite surface protein 1 in Ghanaian children are not associated with protection from clinical malaria.

Authors:  D Dodoo; T G Theander; J A Kurtzhals; K Koram; E Riley; B D Akanmori; F K Nkrumah; L Hviid
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Movement of a falciparum malaria protein through the erythrocyte cytoplasm to the erythrocyte membrane is associated with lysis of the erythrocyte and release of gametes.

Authors:  I A Quakyi; Y Matsumoto; R Carter; R Udomsangpetch; A Sjolander; K Berzins; P Perlmann; M Aikawa; L H Miller
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

Review 3.  Antigenic diversity and immune evasion by malaria parasites.

Authors:  Marcelo U Ferreira; Mônica da Silva Nunes; Gerhard Wunderlich
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

Review 4.  Where are we in the quest for vaccines for malaria?

Authors:  W A Siddiqui
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

5.  Antibody responses to the repetitive Plasmodium falciparum antigen Pf332 in humans naturally primed to the parasite.

Authors:  N Ahlborg; D Haddad; A B Siddique; C Roussilhon; C Rogier; J F Trape; M Troye-Blomberg; K Berzins
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

6.  Cellular responses to a 55-kilodalton recombinant Pneumocystis carinii antigen.

Authors:  S A Theus; D W Sullivan; P D Walzer; A G Smulian
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

7.  Developmental gene expression in Leishmania donovani: differential cloning and analysis of an amastigote-stage-specific gene.

Authors:  H Charest; G Matlashewski
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

8.  The specificity of the antibody response to internal antigens of Ascaris: heterogeneity in infected humans, and MHC (H-2) control of the repertoire in mice.

Authors:  M W Kennedy; L A Tomlinson; E M Fraser; J F Christie
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

9.  Cellular and humoral immune responses to well-defined blood stage antigens (major merozoite surface antigen) of Plasmodium falciparum in adults from an Indian zone where malaria is endemic.

Authors:  L Kabilan; V P Sharma; P Kaur; S K Ghosh; R S Yadav; V S Chauhan
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

10.  T-cell recognition of a cross-reactive antigen(s) in erythrocyte stages of Plasmodium falciparum and Plasmodium yoelii: inhibition of parasitemia by this antigen(s).

Authors:  B Lucas; A Engels; D Camus; A Haque
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.